0001062993-23-003526.txt : 20230214 0001062993-23-003526.hdr.sgml : 20230214 20230214180245 ACCESSION NUMBER: 0001062993-23-003526 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Banerjee Sirshendu Roopom CENTRAL INDEX KEY: 0001926535 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 23632405 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 874706968 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (617)871-2101 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 5 1 form5.xml ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP X0306 5 2022-12-31 0 1 0001907685 Comera Life Sciences Holdings, Inc. CMRA 0001926535 Banerjee Sirshendu Roopom C/O COMERA LIFE SCIENCES HOLDINGS, INC. 12 GILL STREET, SUITE 4650 WOBURN MA 01801 1 0 0 0 Stock Option (Right to Buy) 0.59 2022-05-19 4 A 0 44981 A 2031-09-16 Common Stock 44981 44981 D The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021. This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company. /s/ Ryan M. Rourke Reed, Attorney-in-Fact 2023-02-14